April 7-9, 2016 – Austin, TX USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, is an invited member of the National Visiting Committee for the National Science Foundation (NSF)-supported Bio-Link Regional Center and biotechnology training program at Austin Community College . sites.austincc.edu/biotech nsf.gov/awards/about.jsp January 21-22, 2016 – Corpus Christi, TX USA. […]
January 24-27, 2016 – Washington DC, USA. INCELL was a corporate Sponsor of the 2016 Phacilitate Cell and Gene Therapy World Conference and Bio-Leaders Forum. www.phacilitate.co.uk However, INCELL could not participate and Dr. Moyer was not able to give her panel presentation on “strategic and technological steps in manufacturing” when all flights from San Antonio […]
February 24, 2016-San Antonio, TX USA. READY TO GROW! INCELL received a new Certificate of Occupancy from the City of San Antonio for its adjacent building expansion space of about 10,000 additional square feet at 12746 Cimarron Path, Suite 103. Updating and renovations will commence March 1, 2016. INCELL affiliated companies 4RMED (focused on clinical […]
February 23, 2016-San Antonio, TX USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, and UTHSCSA Professor gave an invited presentation “Managing Integrity as a Core Value in a Biomedical Company” at the University of Texas Health Science Center at San Antonio “Spotlight on Research Integrity” Lecture Series. More Information…
General Description Table 1 shows media designations and supplement options. M3ä Base Medium is a proprietary formula that is a serum-free, highly enriched liquid culture medium for human stem cells and other progenitor and fastidious cell types. It is also useful for culture of animal-derived stem and progenitor cells, tumor cells, and tissues. It […]